Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-23-010656
Filing Date
2023-03-29
Accepted
2023-03-29 17:08:11
Documents
98
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A btmd-20220630.htm   iXBRL 10-Q/A 4580030
2 EX-31.1 btmd-ex31_1.htm EX-31 19624
3 EX-31.2 btmd-ex31_2.htm EX-31 19623
4 EX-32.1 btmd-ex32_1.htm EX-32 12130
5 EX-32.2 btmd-ex32_2.htm EX-32 12130
  Complete submission text file 0000950170-23-010656.txt   16919553

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT btmd-20220630_lab.xml EX-101.LAB 590320
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT btmd-20220630.xsd EX-101.SCH 85859
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT btmd-20220630_cal.xml EX-101.CAL 72341
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT btmd-20220630_pre.xml EX-101.PRE 503306
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT btmd-20220630_def.xml EX-101.DEF 360177
92 EXTRACTED XBRL INSTANCE DOCUMENT btmd-20220630_htm.xml XML 3918310
Mailing Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038
Business Address 1875 W. WALNUT HILL LN #100 IRVING TX 75038 972-486-9346
biote Corp. (Filer) CIK: 0001819253 (see all company filings)

EIN.: 851791125 | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-40128 | Film No.: 23776087
SIC: 2833 Medicinal Chemicals & Botanical Products